REGULAXIS is at the 2019 OARSI conference in Toronto from 2nd-5th of May !

Doctor Christelle Vêtu, CSO and Strategic Business Advisor will present the latest results during the poster session : “Chimeric Peptide combining both Growth Hormone and Somatostatin Sequences (REG-O3) improves function and prevents cartilage degradation in rat model of Osteoarthritis” (POSTER #611).

Meet Dr. Vêtu on Friday, May 3 (3:30 PM – 4:15 PM) and Saturday, May 4 (3:30 PM – 4:15 PM) !